| PACKAGING TYPE: | 10x14 Alu-alu (10 Strip In 1 Box) |
| COMPOSITION: | Each Film Coated Tablet Contains :sacubitril 49mg, Valsartan Ip 51mg, Excipients Q.s |
| FORMULATION: | Tablets |
| Description: | VIOTAN-100 Tablet is a combination of Sacubitril 49 mg and Valsartan 51 mg. It is used for the treatment of chronic heart failure with reduced ejection fraction (HFrEF). This dual-action therapy enhances natriuretic peptide activity (via Sacubitril) and blocks angiotensin II effects (via Valsartan), leading to improved cardiac function, reduced blood pressure, and decreased risk of hospitalization and mortality. |
| Side Effects: | Common: Hypotension (low blood pressure) Dizziness Increased potassium levels Kidney function changes Serious (Rare): Angioedema Severe hypotension Renal impairment Allergic reactions |
| How to Use: | Take as prescribed by a healthcare professional Usually taken twice daily Swallow the tablet with water Can be taken with or without food |
| Precaution: | Monitor blood pressure, kidney function, and potassium levels regularly Do not use with ACE inhibitors (require washout period) Use with caution in patients with renal or hepatic impairment Inform your doctor about all medications being taken Not recommended during pregnancy |
| Product Benefits: | Improves heart function in chronic heart failure Reduces risk of hospitalization and cardiovascular death Promotes vasodilation and reduces fluid overload Enhances quality of life in heart failure patients Provides stronger efficacy compared to lower |
Frequently Asked Questions
It is used for chronic heart failure with reduced ejection fraction (HFrEF).
It contains a higher dose, providing stronger therapeutic effect for patients requiring dose escalation.
Yes, under medical supervision with regular monitoring of blood pressure, kidney function, and electrolytes.












